[3] |
Savinkina AA,Haass KA,Sapiano MRP,et al.Transfusionassociated adverse events and implementation of blood safety measures-findings from the 2017 National Blood Collection and Utilization Survey[J].Transfusion,2020,60 Suppl 2:S10-S16.
|
[13] |
王叶,胡小春,梁翠容,等.输血前预防用药对输血反应发生率影响的Meta 分析[J].循证护理,2017,3(5):446-450.
|
[17] |
Wang SE,Lara PN Jr,Lee-Ow A,et al.Acetaminophen and diphenhydramine as premedication for platelet transfusions:a prospective randomized double-blind placebo-controlled trial[J].Am J Hematol,2002,70(3):191-194.
|
[4] |
Mardani A,Balali MR.Transfusion reactions:A retrospective analysis of the Iranian national haemovigilance system(INHS)data[J].Transfus Apher Sci,2020,59(4):102 767.
|
[5] |
Daurat A,Roger C,Gris J,et al.Apheresis platelets are more frequently associated with adverse reactions than pooled platelets both in recipients and in donors:a study from French hemovigilance data[J].Transfusion,2016,56(6):1295-1303.
|
[8] |
Yamanaka M,Yanagisawa R,Kojima S,et al.Investigation of factors associated with allergic transfusion reaction due to platelet transfusion and the efficacy of platelets resuspended in BRS-A in adult patients[J].Transfusion,2019,59(11):3405-3412.
|
[11] |
Geiger TL,Howard SC.Acetaminophen and diphenhydramine premedication for allergic and febrile nonhemolytic transfusion reactions:good prophylaxis or bad practice?[J].Transfus Med Rev,2007,21(1):1-12.
|
[12] |
Fujiwara SI,Kino S,Tanaka A,et al.A national survey of premedication for transfusion reactions in Japan[J].Transfus Apher Sci,2017,56(5):708-712.
|
[14] |
Duran J,Siddique S,Cleary M.Effects of leukoreduction and premedication with acetaminophen and diphenhydramine in minimizing febrile nonhemolytic transfusion reactions and allergic transfusion reactions during and after blood product administration:a literature review with recommendations for practice[J].J Pediatr Oncol Nurs,2014,31(4):223-229.
|
[15] |
Ning S,Solh Z,Arnold DM,et al.Premedication for the prevention of nonhemolytic transfusion reactions:a systematic review and meta-analysis[J].Transfusion,2019,59(12):3609-3616.
|
[16] |
Aubron C,Aries P,Le Niger C,et al.How clinicians can minimize transfusion-related adverse events?[J].Transfus Clin Biol,2018,25(4):257-261.
|
[2] |
Yazer MH,Shaz B,Seheult JN,et al.Trends in platelet distributions from 2008 to 2017:a survey of twelve national and regional blood collectors[J].Vox Sang,115(8):703-711.
|
[6] |
张晰,冯明亮,沈彤,等.单采血小板输血反应调查及其输注无效解决策略[J].中国输血杂志,2008,21(6):455-457.
|
[7] |
陈利达,芦宏凯,王璐璐,等.北京市某三甲医院输血不良反应回顾分析[J].中国输血杂志,2016,29(2):186-188.
|
[9] |
罗圆圆,陈麟凤,汪德清.132 例血液病患者血小板输注效果的影响因素分析[J].标记免疫分析与临床,2015,22(9):835-838,845
|
[10] |
郝欣欣,高娃,何燕京,等.滤白机采血小板输注不良反应回顾性调查[J].中国输血杂志,2019,32(2):189-192
|
[1] |
Ellingson KD,Sapiano MRP,Haass KA,et al.Continued decline in blood collection and transfusion in the United States-2015[J].Transfusion,2017,57 Suppl 2(Suppl 2):1588-1598.
|